Gilead Sciences, Inc. (FRA:GIS)
90.73
-0.26 (-0.29%)
At close: May 13, 2025
Gilead Sciences Revenue
Gilead Sciences had revenue of $6.67B USD in the quarter ending March 31, 2025, a decrease of -0.28%. This brings the company's revenue in the last twelve months to $28.74B, up 4.68% year-over-year. In the year 2024, Gilead Sciences had annual revenue of $28.75B with 6.04% growth.
Revenue (ttm)
$28.74B
Revenue Growth
+4.68%
P/S Ratio
4.37
Revenue / Employee
$1.63M
Employees
17,600
Market Cap
116.14B EUR
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 28.75B | 1.64B | 6.04% |
Dec 31, 2023 | 27.12B | -165.00M | -0.60% |
Dec 31, 2022 | 27.28B | -24.00M | -0.09% |
Dec 31, 2021 | 27.31B | 2.62B | 10.60% |
Dec 31, 2020 | 24.69B | 2.24B | 9.98% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
SAP SE | 35.15B |
Siemens Aktiengesellschaft | 76.54B |
Deutsche Telekom AG | 118.43B |
Allianz SE | 107.35B |
Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 61.15B |
Rheinmetall AG | 10.48B |
Siemens Energy AG | 37.44B |
Merck KGaA | 21.16B |
Gilead Sciences News
- 10 hours ago - The 2024 Responsible Business and Impact Report Shares How Gilead Sciences Is Driving Change - Wallstreet:Online
- 1 day ago - US stocks close sharply higher on US China tariff news - Forexlive
- 1 day ago - Trump Declares War On Pharma Drug Pricing, But The Stocks Aren't Tanking - Yet - Seeking Alpha
- 5 days ago - Earth Day Focus for Gilead Sciences - Every Action Has an Impact - Wallstreet:Online
- 5 days ago - Marjorie Taylor Greene Goes Stock Shopping Again: Here Are 50+ Stocks The Congresswoman Bought - Benzinga
- 6 days ago - Gilead to invest about $32B in U.S. manufacturing through 2030 - Seeking Alpha
- 6 days ago - Gilead announces $11 billion in new investments in US - Reuters
- 6 days ago - Gilead's Livdelzi® (Seladelpar) Demonstrated Consistent Efficacy and Safety Regardless of ... - GuruFocus